Sign in or register to see full information and data.

Studies / CAVD 571


Study information

Grant Affiliation:Haynes: B cell Lineage Envelope Design from RV144 Antibodies
Strategy:Prophylactic neutralizing Ab
Study Type:Antibody Screening
Species:Non-Organism Study
Stage:Assays Completed
Study Start Date:2016-06-02
Study Made Public:2017-02-08


Neutralization of Memory B-cell Supernatants from RV305 Vacinees


CAVD 571 is an immunogenicity study of B cell culture supernatants from 5 human subjects from study RV305.


ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/E

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.